These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19920936)

  • 1. Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan.
    Ryuge S; Jiang SX; Wada M; Katono K; Iwasaki M; Takakura A; Otani S; Kimura Y; Fukui T; Yokoba M; Kubota M; Katagiri M; Hayakawa K; Masuda N
    Drug Des Devel Ther; 2009 Sep; 3():213-7. PubMed ID: 19920936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma.
    Kasahara N; Wakuda K; Omori S; Nakashima K; Ono A; Taira T; Kenmotsu H; Naito T; Murakami H; Mori K; Watanabe R; Endo M; Nakajima T; Yamada M; Takahashi T
    Mol Clin Oncol; 2017 May; 6(5):718-722. PubMed ID: 28529747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An elderly patient with large cell neuroendocrine carcinoma(LCNEC)for whom chemotherapy with irinotecan and split-dose cisplatin(CDDP)proved very effective].
    Tanno S; Onodera H; Inoue S; Honda R; Nagashima K; Ohsaki Y
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1205-8. PubMed ID: 24047780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
    Kawabe T; Yamamoto M; Sato Y; Yomo S; Kondoh T; Nagano O; Serizawa T; Tsugawa T; Okamoto H; Akabane A; Aita K; Sato M; Jokura H; Kawagishi J; Shuto T; Kawai H; Moriki A; Kenai H; Iwai Y; Gondo M; Hasegawa T; Yasuda S; Kikuchi Y; Nagatomo Y; Watanabe S; Hashimoto N
    J Neurosurg; 2016 Dec; 125(Suppl 1):11-17. PubMed ID: 27903179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
    Kenmotsu H; Niho S; Ito T; Ishikawa Y; Noguchi M; Tada H; Sekine I; Watanabe S; Yoshimura M; Yamamoto N; Oshita F; Kubota K; Nagai K
    Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
    Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
    Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with irinotecan and cisplatin for large-cell neuroendocrine carcinoma of the lung: a multicenter phase II study.
    Niho S; Kenmotsu H; Sekine I; Ishii G; Ishikawa Y; Noguchi M; Oshita F; Watanabe S; Nakajima R; Tada H; Nagai K
    J Thorac Oncol; 2013 Jul; 8(7):980-4. PubMed ID: 23774385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
    Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
    Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Large Cell Neuroendocrine Carcinoma.
    Corbett V; Arnold S; Anthony L; Chauhan A
    Front Oncol; 2021; 11():653162. PubMed ID: 34513663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survivor of pulmonary combined large cell neuroendocrine carcinoma treated with nivolumab.
    Oda R; Okuda K; Yamashita Y; Sakane T; Tatematsu T; Yokota K; Endo K; Nakanishi R
    Thorac Cancer; 2020 Jul; 11(7):2036-2039. PubMed ID: 32379390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey.
    Ustaalioglu BBO; Ulas A; Esbah O; Turan N; Bilici A; Demirci U; Alkıs N; Seker M; Oksuzoglu B; Gumus M;
    Thorac Cancer; 2013 May; 4(2):161-166. PubMed ID: 28920204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of large cell neuroendocrine carcinoma and small cell lung carcinoma in high-grade neuroendocrine tumors of the lung: a large population-based study.
    Wang J; Ye L; Cai H; Jin M
    J Cancer; 2019; 10(18):4226-4236. PubMed ID: 31413741
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis.
    Yang Q; Xu Z; Chen X; Zheng L; Yu Y; Zhao X; Chen M; Luo B; Wang J; Sun J
    Thorac Cancer; 2019 Apr; 10(4):751-760. PubMed ID: 30734490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic large cell neuroendocrine carcinoma of the lung arising from the uterus: A pitfall in lung cancer diagnosis.
    Ono K; Yokota NR; Yoshioka E; Noguchi A; Washimi K; Kawachi K; Miyagi Y; Kato H; Yokose T
    Pathol Res Pract; 2016 Jul; 212(7):654-7. PubMed ID: 27113439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
    Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
    Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical study of advanced large cell neuroendocrine carcinoma].
    Kishi K; Homma S; Takaya H; Miyamoto A; Sakamoto S; Kurosaki A; Motoi N; Yoshimura K
    Nihon Kokyuki Gakkai Zasshi; 2006 Aug; 44(8):556-60. PubMed ID: 16972612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases.
    Atieh T; Huang CH
    Front Oncol; 2021; 11():667468. PubMed ID: 34178652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on large cell neuroendocrine carcinoma.
    Hiroshima K; Mino-Kenudson M
    Transl Lung Cancer Res; 2017 Oct; 6(5):530-539. PubMed ID: 29114469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.
    Le Treut J; Sault MC; Lena H; Souquet PJ; Vergnenegre A; Le Caer H; Berard H; Boffa S; Monnet I; Damotte D; Chouaid C
    Ann Oncol; 2013 Jun; 24(6):1548-52. PubMed ID: 23406729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.